Clinical Trial Update: Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing stress ulcer prophylaxis versus placebo in critically ill infants with congenital heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Upper Gastrointestinal Bleeding

Snippet

Sponsor: Boston Children's Hospital | Conditions: Congenital Heart Disease, Upper Gastrointestinal Bleeding | Phase 4 | Status: COMPLETED